LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p/E2F7 axis and activating VEGFR-2 signaling pathway in hepatocellular carcinoma. (33168027)
user: 0
Pubmeds:
Login
For any questions and suggestions, write to us by mail: info@onco.io